World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
37777
World Ranking
13443
National Ranking
6837

Overview

Mikhail Kosiborod is affiliated with the University of Missouri-Kansas City in the United States and specializes in medical research with a focus on endocrinology, diabetes, metabolism, and cardiology. Their scholarly output consists of over a thousand publications, primarily centered on diabetes treatment and management, as well as heart failure treatment.

Their research spans several interconnected fields, including:

  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Molecular Biology
  • Pulmonary and Respiratory Medicine

Major topics in their work comprise:

  • Diabetes Treatment and Management
  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Pancreatic Function and Diabetes
  • Diabetes Management and Research
  • Metabolism, Diabetes, and Cancer
  • Potassium and Related Disorders

Recent notable papers by Kosiborod include:

  • "Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity," 2023, published in the New England Journal of Medicine

Other significant papers relevant to their research area, which they coauthored or collaborated on within the broader community, include:

  • "Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction," 2022, New England Journal of Medicine
  • "Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease," 2020, New England Journal of Medicine
  • "Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association," 2023, Circulation
  • "SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials," 2022, The Lancet

Frequent co-authors working closely with Kosiborod include:

  • John J.V. McMurray
  • Scott D. Solomon
  • Pardeep S. Jhund
  • Silvio E. Inzucchi
  • Felipe A. Martínez

Publication venues where Kosiborod's contributions appear frequently include:

  • Circulation
  • Journal of the American College of Cardiology
  • European Journal of Heart Failure
  • JACC Heart Failure
  • European Heart Journal

Best Publications

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino

  • Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline

    Guillermo E. Umpierrez;Richard Hellman;Mary T. Korytkowski;Mikhail Kosiborod

  • Excess Mortality among Persons with Type 2 Diabetes

    Mauro Tancredi;Annika Rosengren;Ann-Marie Svensson;Mikhail Kosiborod

  • The obesity paradox: body mass index and outcomes in patients with heart failure.

    Jeptha P. Curtis;Jared G. Selter;Yongfei Wang;Saif S. Rathore

  • Glycemic Control and Excess Mortality in Type 1 Diabetes

    Marcus Lind;Ann-Marie Svensson;Mikhail Kosiborod;Soffia Gudbjörnsdottir

  • Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).

    Mikhail Kosiborod;Matthew A. Cavender;Alex Z. Fu;John P. Wilding

  • Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes.

    Mikhail Kosiborod;Saif S. Rathore;Silvio E. Inzucchi;Frederick A. Masoudi

  • Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.

    Deepak L. Bhatt;Michael Szarek;Bertram Pitt;Christopher P. Cannon

  • Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006.

    Héctor Bueno;Joseph S. Ross;Yun Wang;Jersey Chen

  • Contemporary Incidence, Predictors, and Outcomes of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions : Insights From the NCDR Cath-PCI Registry

    Thomas T. Tsai;Thomas T. Tsai;Uptal D. Patel;Tara I. Chang;Kevin F. Kennedy

  • Glucometrics in Patients Hospitalized With Acute Myocardial Infarction Defining the Optimal Outcomes-Based Measure of Risk

    Mikhail Kosiborod;Silvio E. Inzucchi;Harlan M. Krumholz;Lan Xiao

  • Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update

    Shannon M. Dunlay;Michael M. Givertz;David Aguilar;Larry A. Allen

  • The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.

    Michael E Nassif;Sheryl L Windsor;Barry A Borlaug;Dalane W Kitzman

  • Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study

    Mikhail Kosiborod;Carolyn S.P. Lam;Shun Kohsaka;Dae Jung Kim;Dae Jung Kim

  • Worsening renal function: What is a clinically meaningful change in creatinine during hospitalization with heart failure?

    Grace L. Smith;Viola Vaccarino;Mikhail Kosiborod;Judith H. Lichtman

  • Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes

    Mark C Petrie;Subodh Verma;Kieran F Docherty;Silvio E Inzucchi

  • Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction.

    Mikhail Kosiborod;Silvio E. Inzucchi;Abhinav Goyal;Harlan M. Krumholz

  • Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

    Jay S. Skyler;Richard Bergenstal;Robert O. Bonow;John Buse

  • Cardiovascular Outcomes and Mortality in Type 2 Diabetes with Associated Cardio-Renal-Metabolic Comorbidities

    Suzanne V. Arnold;Phillip R. Hunt;Hungta Chen;Sharon Maclachlan

Frequent Co-Authors

John A. Spertus
John A. Spertus University of Missouri–Kansas City
Silvio E. Inzucchi
Silvio E. Inzucchi Yale University
Darren K. McGuire
Darren K. McGuire The University of Texas Southwestern Medical Center
Marc S. Sabatine
Marc S. Sabatine Brigham and Women's Hospital
Scott D. Solomon
Scott D. Solomon Brigham and Women's Hospital
Frederick A. Masoudi
Frederick A. Masoudi University of Colorado Anschutz Medical Campus
John J.V. McMurray
John J.V. McMurray University of Glasgow
Niklas Hammar
Niklas Hammar Karolinska Institute
Harlan M. Krumholz
Harlan M. Krumholz Yale University
Lars Køber
Lars Køber Copenhagen University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their career options beyond traditional medical school, there are a range of online degrees and healthcare pathways to consider. Many practicing nurses pursue advancement through affordable degree completion programs, such as cheap rn to bsn online programs designed to boost credentials and open doors to leadership roles.

Individuals without a nursing background can explore online direct entry msn programs for non-nurses, allowing them to quickly pivot into advanced nursing careers. These programs provide a fast-track option for those holding a non-nursing bachelor’s degree, helping ease entry into the healthcare sector.

If you’re concerned about program competitiveness, there are nursing schools with high acceptance rates that provide accessible pathways into the field. For those interested in healthcare administration, medical billing and coding schools that accept financial aid offer online study options, helping students begin a stable career without a heavy financial burden.

Best Scientists Citing Mikhail Kosiborod

Trending Scientists

Recently Published Articles